These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 33635220

  • 1. Clinical manifestations and outcome of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody positive patients with interstitial lung disease.
    Feng L, Wang H, Zhao Y, Zhao T, Zhang J, Huang F, Zhu J.
    Clin Exp Rheumatol; 2022 Jan; 40(1):97-103. PubMed ID: 33635220
    [Abstract] [Full Text] [Related]

  • 2. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [Abstract] [Full Text] [Related]

  • 3. Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody.
    Isoda K, Kotani T, Takeuchi T, Kiboshi T, Hata K, Ishida T, Otani K, Kamimori T, Fujiwara H, Shoda T, Makino S.
    Rheumatol Int; 2017 Aug; 37(8):1335-1340. PubMed ID: 28451794
    [Abstract] [Full Text] [Related]

  • 4. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis.
    Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumata Y, Takagi K, Masuda I, Tochimoto A, Baba S, Okamoto Y, Ota Y, Yamanaka H.
    Rheumatology (Oxford); 2010 Sep; 49(9):1713-9. PubMed ID: 20498012
    [Abstract] [Full Text] [Related]

  • 5. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T.
    Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490
    [Abstract] [Full Text] [Related]

  • 6. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
    Chen X, Zhang L, Jin Q, Lu X, Lei J, Peng Q, Wang G, Ge Y.
    Front Immunol; 2022 Jan; 13():987841. PubMed ID: 36110863
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.
    Motegi SI, Sekiguchi A, Toki S, Kishi C, Endo Y, Yasuda M, Ikeuchi H, Sakairi T, Hara K, Yamaguchi K, Maeno T, Hiromura K, Ishikawa O.
    Eur J Dermatol; 2019 Oct 01; 29(5):511-517. PubMed ID: 31617496
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease.
    Wakura R, Matsuda S, Kotani T, Shoda T, Takeuchi T.
    Sci Rep; 2020 Sep 24; 10(1):15692. PubMed ID: 32973255
    [Abstract] [Full Text] [Related]

  • 12. Relevance of leukaemia inhibitory factor to anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease.
    Ichimura Y, Ikei H, Konishi R, Zeniya M, Okai T, Nomura T, Negishi K, Okiyama N.
    Rheumatology (Oxford); 2023 Jun 01; 62(6):2267-2271. PubMed ID: 36326445
    [Abstract] [Full Text] [Related]

  • 13. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
    Sakamoto S, Okamoto M, Kaieda S, Fujimoto K, Nagata S, Tominaga M, Nakamura M, Zaizen Y, Nouno T, Koga T, Kawayama T, Kuwana M, Ida H, Hoshino T.
    Respir Investig; 2018 Nov 01; 56(6):464-472. PubMed ID: 30150008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease.
    Matsushita T, Kobayashi T, Kano M, Hamaguchi Y, Takehara K.
    J Dermatol; 2019 Dec 01; 46(12):1190-1196. PubMed ID: 31631384
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease.
    Kaieda S, Gono T, Masui K, Nishina N, Sato S, Kuwana M, A Multicenter Retrospective Cohort of Japanese Patients with Myositis-associated ILD (JAMI) investigators.
    PLoS One; 2020 Dec 01; 15(6):e0234523. PubMed ID: 32525903
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
    Asakawa K, Yoshizawa K, Aoki A, Kimura Y, Tanaka T, Ohashi K, Hayashi M, Kikuchi T, Sato S, Takada T.
    Clin Rheumatol; 2020 Jul 01; 39(7):2171-2178. PubMed ID: 32056068
    [Abstract] [Full Text] [Related]

  • 19. Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study.
    Dunga SK, Kavadichanda C, Gupta L, Naveen R, Agarwal V, Negi VS.
    Rheumatol Int; 2022 Jul 01; 42(7):1155-1165. PubMed ID: 34050793
    [Abstract] [Full Text] [Related]

  • 20. [Clinical characteristics and prognostic factors of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated interstitial lung disease].
    Zou RY, Zhao Q, Tian YQ, Yan X, Qiu XH, Gao YJ, Liu Y, Huang M, Cao M, Dai JH, Cai HR.
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Aug 12; 46(8):781-790. PubMed ID: 37536988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.